Prestige Biologics withdraws planned reverse stock split after Sept. 30 vote rejection

Prestige Biologics withdrew its planned reverse stock split after rejection at its 12th annual shareholders’ meeting on Sept. 30, 2026, correcting a Sept. 11, 2026 disclosure on the consolidation plan and related par value changes.